Consultant cardiologist Chris Ellis discusses the recent funding of rosuvastatin, focusing on its use for secondary prevention of cardiovascular disease
Professor Ngaire Kerse says new medicines for heart failure have appeared in recent years. With optimised use, these support the main goal of treatment, which is periods of stability with good quality of life
A world-first personalised benefit-harm calculator developed in Aotearoa New Zealand will help people decide, with their doctors, if they should take a daily aspirin as a preventative against heart disease and stroke.